Viewing nowPregabalin Capsule 50 mg (Pregabalin)
Pregabalin 50mg
Hard capsule · Prescription medication
Myungjin Pharmaceutical Co., Ltd.

MFDS item code 201804578 · Approved 2018.11.19 · Insurance code 651904680
Treatment of neuropathic pain and fibromyalgia; adjunctive treatment of partial-onset seizures
This medication is used to treat peripheral and central neuropathic pain in adults. It is also used as an adjunct for partial seizures in patients with epilepsy, applicable in both cases whether accompanied by secondary generalized symptoms or not. Additionally, it is effective for the treatment of fibromyalgia. This medication is used to improve symptoms of various neurological-related disorders.
The total daily dose of this medicine, as pregabalin, is administered orally in 2 divided doses, regardless of food. This medicine is excreted primarily by the kidneys; therefore, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with renal impairment’) 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: This medicine may be administered at an initial dose of 150 mg per day. Based on each patient's response and tolerability, the dose may be increased to 300 mg per day after 3 to 7 days. If necessary, it may subsequently be increased at 7-day intervals to a maximum of 600 mg per day. 2) Central neuropathic pain Adults: This medicine may be administered at an initial dose of 150 mg per day. Based on each patient's response and tolerability, the dose may be increased to 300 mg per day after 1 week. It may be further increased to the target daily dose of 600 mg after an additional 1 week. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation’) 2. Epilepsy Adults: This medicine may be administered at an initial dose of 150 mg per day. Based on each patient's response and tolerability, the dose may be increased to 300 mg per day after 1 week. If necessary, it may subsequently be increased at 7-day intervals to a maximum of 600 mg per day. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg per day. The initial dose is 75 mg twice daily (150 mg per day), and based on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg per day). For patients who do not experience sufficient benefit at a dose of 300 mg per day, the dose may be increased within 1 week to 225 mg twice daily (450 mg per day). Clinical studies have also been conducted at a dose of 600 mg per day; however, there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg per day are not recommended. 4. Discontinuation Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually over a period of at least 1 week. 5. Patients with renal impairment Dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, a supplemental dose should be administered promptly after each 4-hour hemodialysis session. Creatinine clearance (CLcr), (mL/min) ≥60: Initial dose 150 (mg/day), maximum dose 600 (mg/day), BID or TID Creatinine clearance (CLcr), (mL/min) ≥30 -<60: Initial dose 75 (mg/day), maximum dose 300 (mg/day), BID or TID Creatinine clearance (CLcr), (mL/min) ≥15 -<30: Initial dose 25-50 (mg/day), maximum dose 150 (mg/day), QD or BID Creatinine clearance (CLcr), (mL/min) <15: Initial dose 25 (mg/day), maximum dose 75 (mg/day), QD Supplemental dose after hemodialysis: Initial dose 25, maximum dose 100, single dose TID = Divide the total daily dose into 3 doses BID = Divide the total daily dose into 2 doses QD = Administer once daily a: The total daily dose (mg/day) should be divided as specified in the method of administration. b: The supplemental dose is an additional dose administered once. 6. Patients with hepatic impairment No dose adjustment is required in patients with hepatic impairment. 8. Older adults (65 years and older) Dose reduction may be necessary in older adults with impaired renal function.
Children under 12 years of age: Administration is not recommended because there are insufficient safety and efficacy data. Adolescent patients aged 12 ~17 years: Administration is not recommended because there are insufficient safety and efficacy data.
This medication may increase the risk of suicidal thoughts or behaviors, so immediately inform a healthcare professional if mood changes or depressive symptoms arise during use. Do not take this medication if there is hypersensitivity to it or if there are specific genetic issues such as lactose intolerance. Diabetic patients should be cautious as weight gain may require adjustment of blood glucose control medication. If any symptoms of angioedema appear, discontinue this medication immediately, and elderly patients should be careful of the risk of falls due to dizziness or drowsiness. Vision blur or changes in eyesight may occur, so consult a healthcare professional if symptoms arise. Abrupt discontinuation of this medication may lead to withdrawal symptoms such as insomnia, headaches, or anxiety, so adjustments should be made in consultation with a healthcare professional. Patients with a history of substance abuse may have a higher risk of abuse with this medication and should take it cautiously while carefully observing signs of drug misuse. Patients with reduced kidney function may require dosage adjustments. Patients with heart disease should be carefully monitored when taking this medication. Taking this medication along with other central nervous system depressants may increase the risk of respiratory depression and other side effects, so caution is warranted. In the early stages of pregnancy, there is a risk of fetal malformation, so pregnant women should not take it unless absolutely necessary, and women of childbearing age should use effective contraception. Breastfeeding mothers should consult a healthcare professional regarding the possibility of transfer to breast milk and whether to discontinue breastfeeding or the medication. Caution should be exercised while driving or operating machinery due to the risk of accidents from dizziness and drowsiness. This medication may cause serious skin adverse reactions, so if symptoms such as skin rash or fever occur, discontinue use immediately and consult a healthcare professional. In case of overdose, symptoms such as confusion, drowsiness, depression, and seizures may occur, and immediate hospital visit for proper treatment is necessary. This medication should be kept out of the reach of children, and it is advisable to avoid transferring it to another container as it may reduce quality or pose risk of accidents.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. Additionally, it is best to store it at room temperature between 15 and 30 degrees Celsius.
A hard capsule with a dark blue upper and white lower, containing a white powder that is white or light yellow in color.
30 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 50mg
Hard capsule · Prescription medication
Myungjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.